Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Dec 1;180(6):2335-40.
doi: 10.1084/jem.180.6.2335.

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus

Affiliations

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus

V P Argaet et al. J Exp Med. .

Abstract

To examine T cell receptor (TCR) diversity involved in the memory response to a persistent human pathogen, we determined nucleotide sequences encoding TCR-alpha and -beta chains from HLA-B8-restricted, CD8+ cytotoxic T cell clones specific for an immunodominant epitope (FLRGRAYGL) in Epstein-Barr virus (EBV) nuclear antigen 3. Herein, we show that identical TCR protein sequences are used by clones from each of four healthy unrelated virus carriers; a clone from a fifth varied conservatively at only two residues. This dominant selection of alpha and beta chain rearrangements suggest that a persistent viral infection can select for a highly focused memory response and indicates a strong bias in gene segment usage and recombination. A novel double-step semiquantitative polymerase chain reaction (PCR) procedure and direct sequencing of amplified TCR cDNA from fresh lymphocytes derived from three HLA-B8 individuals detected transcripts specific for the conserved beta chain in an EBV-seropositive donor but not in two seronegative donors. This report describes an unprecedented degree of conservation in TCR selected in response to a natural persistent infection.

PubMed Disclaimer

References

    1. J Exp Med. 1994 Apr 1;179(4):1261-71 - PubMed
    1. J Exp Med. 1994 Apr 1;179(4):1155-61 - PubMed
    1. Int J Cancer. 1984 Feb 15;33(2):239-43 - PubMed
    1. Immunol Rev. 1984 Jun;79:119-38 - PubMed
    1. Nature. 1985 Aug 29-Sep 4;316(6031):837-40 - PubMed

Publication types

MeSH terms

Substances